Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Drug Discovery

Discovery & Development Drug Discovery

Allergy Relief

| Maryam Mahdi

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

Discovery & Development Drug Discovery

A Step Closer to a Universal Flu Vaccine

| Maryam Mahdi

Can newly discovered antibodies help us do away with annual flu vaccinations?

Discovery & Development Drug Discovery

Checkmate for Cachexia?

| Angus Stewart

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.

Discovery & Development Dosage Forms

Gilead Goes Ferreting

| Angus Stewart

A partnership between Gilead Sciences and Georgia State University has tested a new oral antiviral for COVID-19.

Business & Regulation Business Practice

Adding More Seats to the Table

| Gary Nolan

To optimize drug development, the opinions of all stakeholders – including patients – must be heard.

Discovery & Development Business Practice

A Roadmap to Improved Drug Access in the Global South

| Greg S Garrett, Jean-Michel Piedagnel

Two members of the Drugs for Neglected Diseases initiative lay out how they improved access to Hep C treatment in Southeast Asia and beyond.

Discovery & Development Drug Discovery

The Next Frontier in HIV Prevention

| Maryam Mahdi

Exploring the potential of vaccines for treatment equity.

Discovery & Development Drug Discovery

Slowing the Alzheimer’s Decline | The Medicine Maker Social

| Maryam Mahdi

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

Discovery & Development Drug Discovery

The Tale of Two TULIPs

| Angus Stewart

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Discovery & Development Drug Discovery

ADCs: Still Room for Improvement!

| Antoine Attinger

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register